We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

WERFEN

Werfen provides diagnostic instruments for critical care and hemostasis to meet the testing needs of medical professi... read more Featured Products: More products

Download Mobile App





Werfen Showcases Latest Innovations in Specialized Diagnostics

By LabMedica International staff writers
Posted on 22 May 2023
Print article
Image: The GEM Premier 5000 whole-blood, blood gas testing system (Photo courtesy of Werfen)
Image: The GEM Premier 5000 whole-blood, blood gas testing system (Photo courtesy of Werfen)

Werfen (Barcelona, Spain) is participating in the 2023 WordLab-EuroMedLab Congress, the leading event in the field of laboratory medicine and clinical chemistry that brings together top experts and scientists from around the world. As a silver sponsor of the Congress, Werfen is welcoming visitors at La Nuvola Convention Center in Rome to its futuristic 80 square meters booth, ready to present its innovations in specialized diagnostics through its products and solutions.

Werfen provides advanced in vitro diagnostic solutions, catering to both point-of-care and lab testing needs. Its acute care diagnostic solutions address healthcare challenges across various healthcare settings, including cardiovascular operating rooms, catheterization labs, intensive care units, and emergency departments, improving efficiency and enhance patient care. At EuroMedLab Rome 2023, Werfen is highlighting its comprehensive and integrated line of acute care diagnostics. This includes the company’s blood gas family, featuring the GEM Premier and Avoximeter product lines, as well as the whole blood hemostasis family, featuring the ROTEM, Hemochron, and VerifyNow product lines.

As an active player in scientific knowledge, Werfen is promoting two educational sessions that will take place during the event. The first session titled 'Leveraging Innovative Technology to Optimize Quality in Point-of-Care Blood Gas Testing' will start by offering insights into the sources of preanalytical errors in point-of-care testing, followed by identification of the benefits of automated, continuous quality assurance vs. intermittent liquid quality control (QC). The speakers will identify strategies to address the risks of variability in sample collection, for enhanced patient safety and review the history of QC and novel Patient-Based, Real-Time QC. The session will conclude with a review of strategies to achieve higher quality standards with proactive tracking and monitoring of KPIs, using data management solutions.

The second session titled 'The value of experience in coagulation and autoimmunity. Werfen, Powering Patient Care' will focus on the value that automation and dedicated data management solutions, combined with the company's high specialization, can offer to laboratorians and clinicians, in Hemostasis and Autoimmunity, to ensure the best levels of patient care. In addition, the speaker will explain the organizational advantages of shortened turnaround time while increasing laboratory efficiency.

Werfen is also sponsoring the Satellite Meeting “Point-of-Care Testing: Home, Hospital and Beyond” - a forum for companies and industry experts to discuss topics around innovations and the future of POCT. In his talk “POC Organizational Models in the World and IT Solutions”, Davide Colombo, Global Acute Care Expert at Werfen, will share hospital organizational models and POC technology know-how in different countries, as well as explain the industry's role in the success of these organizations.

Related Links:
Werfen

HLX
New
Gold Supplier
Foam Tipped Applicator
PurSwab 5"
New
UHF RFID Tag and Inlay
AD-163u8
New
Platinum Supplier
Diagnostic Reader
Acucy System

Print article

Channels

Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Hematology

view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more

Immunology

view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more

Microbiology

view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more

Pathology

view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more

Technology

view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more

Industry

view channel
Image: The Coris acquisition provides Avacta with a broad, professional-use rapid test product portfolio (Photo courtesy of Coris Bioconcept)

Avacta Expands Diagnostics Portfolio with Acquisition of Rapid Test Maker Coris Bioconcept

Avacta Group plc (London, UK), a life sciences company developing oncology drugs and diagnostics, has acquired Coris Bioconcept SRL (Gembloux, Belgium) for an upfront cash consideration of GBP 7.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.